David Casadevall
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 6
- Cancer Cells and Metastasis 3
- COVID-19 and healthcare impacts 3
- HER2/EGFR in Cancer Research 2
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Joan Albanell (13 shared papers)Edurne Arriola (11 shared papers)Álvaro Taus (11 shared papers)Sílvia Menéndez (6 shared papers)Sergi Clavé (8 shared papers)Marta Lorenzo (5 shared papers)Lara Pijuán (8 shared papers)Marta Salido (8 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Journal of Thoracic Oncology (4 papers)Annals of Oncology (3 papers)Clinical Cancer Research (2 papers)Scientific Reports (2 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
David Casadevall
26 papers receiving 395 citations
Peers
Comparison fields: 5 of 53
- Oncology 185
- Cancer Research 98
- Obstetrics and Gynecology 30
- Pulmonary and Respiratory Medicine 100
- Hepatology 18
Countries citing papers authored by David Casadevall
This map shows the geographic impact of David Casadevall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Casadevall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Casadevall more than expected).
Fields of papers citing papers by David Casadevall
This network shows the impact of papers produced by David Casadevall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Casadevall. The network helps show where David Casadevall may publish in the future.
Co-authors
The 25 scholars most cited alongside David Casadevall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 70 | |
| 2 | 2021 | 63 | |
| 3 | 2015 | 50 | |
| 4 | 2019 | 42 | |
| 5 | 2017 | 31 | |
| 6 | 2021 | 28 | |
| 7 | 2017 | 23 | |
| 8 | 2023 | 18 | |
| 9 | 2022 | 17 | |
| 10 | 2016 | 8 | |
| 11 | 2024 | 6 | |
| 12 | 2023 | 6 | |
| 13 | 2020 | 6 | |
| 14 | 2022 | 4 | |
| 15 | 2015 | 4 | |
| 16 | 2020 | 4 | |
| 17 | 2022 | 3 | |
| 18 | 2014 | 3 | |
| 19 | 2019 | 3 | |
| 20 | 2022 | 2 |
About David Casadevall
David Casadevall is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Infectious Diseases, having authored 31 papers that have together received 398 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Cells and Metastasis (3 papers), COVID-19 and healthcare impacts (3 papers), COVID-19 Impact on Reproduction (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Oncology (185 citations), Cancer Research (98 citations), Obstetrics and Gynecology (30 citations), Pulmonary and Respiratory Medicine (100 citations) and Hepatology (18 citations). David Casadevall has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Joan Albanell, Edurne Arriola, Álvaro Taus, Sílvia Menéndez, Sergi Clavé, Marta Lorenzo, Lara Pijuán, Marta Salido, Joaquim Bellmunt and Max Hardy-Werbin. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Clinical Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.